Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M420Revenue $M54.2Net Margin (%)-104.0Z-Score-6.9
Enterprise Value $M527EPS $-0.4Operating Margin %-177.0F-Score4
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-109.2Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio3.3Cash flow > EarningsN
Price/Sales7.65-y EBITDA Growth Rate %-20.3Current Ratio3.6Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-27.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)0Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M175ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with AMRN

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMRNJohn Burbank 2013-03-31 Sold Out -0.08%$6.965 - $9.16
($8.27)
$ 2.37-249%Sold Out0
AMRNJohn Burbank 2012-12-31 Buy 0.08%$7.68 - $12.6
($10.8)
$ 2.37-356%New holding250,000
AMRNGeorge Soros 2012-09-30 Sold Out -0.06%$11.17 - $15.49
($13.55)
$ 2.37-472%Sold Out0
AMRNGeorge Soros 2012-06-30 Buy 0.06%$9.47 - $14.74
($11.35)
$ 2.37-379%New holding300,000
AMRNGeorge Soros 2011-09-30 Sold Out -0.058%$8.95 - $14.82
($12)
$ 2.37-406%Sold Out0
AMRNGeorge Soros 2011-06-30 Reduce-0.04%$7.39 - $19.5
($15)
$ 2.37-533%Reduce -56.15%285,000
AMRNGeorge Soros 2011-03-31 Reduce-0.04%$7.03 - $9.33
($8.1)
$ 2.37-242%Reduce -42.66%650,000
AMRNGeorge Soros 2010-12-31 Buy 0.12%$2.49 - $8.49
($4.48)
$ 2.37-89%New holding1,133,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMRN is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


AMRN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
THERO JOHN FPresident, Chief Exec. Officer 2014-11-12Buy50,000$0.83172.29view
Farrell Michael JamesController 2014-11-11Buy5,500$0.84169.05view
Southpoint Capital Advisors LP10% Owner 2006-04-20Sell0$0169.05view

Press Releases about AMRN :

    Quarterly/Annual Reports about AMRN:

    News about AMRN:

    Articles On GuruFocus.com
    Morning Coffee: Widely Held International Guru Stocks Near 52-Week Lows May 23 2014 
    Weekly Guru Bargains Highlights: PANL, THRX, ZNGA, LORL, AMRN Jan 07 2013 
    Steven Cohen Adds Amarin Corp. Awaiting Drug Approval, Buys Hyatt Hotels Mar 28 2012 
    Soros Funds’ Great Britain Buys and Sells Apr 13 2011 

    More From Other Websites
    Amarin, LeapFrog Lead Monday's After-Hours Movers Mar 16 2015
    New In Vitro Study Presented at the American College of Cardiology Meeting Suggests Omega-3 Fatty... Mar 16 2015
    New In Vitro Study Presented at the American College of Cardiology Meeting Suggests Omega-3 Fatty... Mar 16 2015
    8 Analyst Stocks Under $10 With Massive Upside Calls Mar 14 2015
    3 Biotech Stocks on Traders' Radars: Technical Charts Mar 13 2015
    Biotech Stock Mailbag: Neuralstem, Genfit, Intercept, Amarin Mar 13 2015
    Top Analyst Upgrades and Downgrades: Amarin, CONSOL, Garmin, GNC, HP, Peabody, Windstream and More Mar 12 2015
    Wednesday's After-Hours Movers: Shake Shack, Box And Others Fall Following Earnings Mar 11 2015
    AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale... Mar 11 2015
    Amarin Announces $52.8 Million Private Placement Mar 06 2015
    Amarin Announces $52.8 Million Private Placement Mar 06 2015
    New In Vitro Study Presented at DEUEL Conference on Lipids Suggests Combination Omega-3 Fatty Acid... Mar 04 2015
    New In Vitro Study Presented at DEUEL Conference on Lipids Suggests Combination Omega-3 Fatty Acid... Mar 04 2015
    Amarin to Host Fourth Quarter and Fiscal Year 2014 Earnings Conference Call and Webcast Live on... Mar 03 2015
    Amarin to Report Fourth Quarter and Year-End 2014 Results and Host Conference Call on March 3, 2015 Mar 03 2015
    Amarin Reports Fourth Quarter and Year-End 2014 Financial Results and Provides Update on Operations Mar 03 2015
    Amarin Reports Fourth Quarter and Year-End 2014 Financial Results and Provides Update on Operations Mar 03 2015
    Amarin to Host Fourth Quarter and Fiscal Year 2014 Earnings Conference Call and Webcast Live on... Mar 02 2015
    What's in Store for Geron (GERN) this Earnings Season? - Analyst Blog Mar 02 2015
    Intercept Pharmaceuticals (ICPT): Will It Miss Q4 Earnings? - Analyst Blog Feb 28 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK